Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia
暂无分享,去创建一个
H. Dombret | F. Lacombe | E. Macintyre | A. Delannoy | P. Chevallier | M. Béné | X. Thomas | N. Ifrah | P. Rousselot | A. Buzyn | M. Maynadié | E. Raffoux | E. Kuhlein | Y. Chalandon | J. Vernant | S. Maury | F. Huguet | A. de Labarthe | T. Leguay | S. Girard | M. Maynadie
[1] H. Kantarjian,et al. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. , 2009, Blood.
[2] H. Dombret,et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] D. Hoelzer,et al. Treatment of adult acute lymphoblastic leukemia. , 2009, Seminars in hematology.
[4] M. Konopleva,et al. Outcome after Frontline Therapy with the Modified Hyper-CVAD Regimen with or without Rituximab for De Novo Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL). , 2008 .
[5] G. Basso,et al. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. , 2008, Blood.
[6] J. Esteve,et al. High‐dose chemotherapy and immunotherapy in adult Burkitt lymphoma , 2008, Cancer.
[7] J. Cayuela,et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study , 2006 .
[8] F. Behm,et al. Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia. , 2006, Blood.
[9] H. Kantarjian,et al. Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia , 2006, Cancer.
[10] D. Hoelzer,et al. Treatment of adult acute lymphoblastic leukemia. , 1999, Hematology. American Society of Hematology. Education Program.
[11] M. Schrappe,et al. Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia. , 2006, Haematologica.
[12] R. Foà,et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. , 2005, Blood.
[13] M. van Buchem,et al. Optic nerve relapse in a child with common acute lymphoblastic leukemia, treated with systemic anti-CD-20 (rituximab). , 2005, Haematologica.
[14] D. Hoelzer,et al. Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects , 2004, Annals of Hematology.
[15] F. Niggli,et al. Induction of Long-Term Remission of a Relapsed Childhood B–Acute Lymphoblastic Leukemia With Rituximab Chimeric Anti-CD20 Monoclonal Antibody and Autologous Stem Cell Transplantation , 2003, Journal of pediatric hematology/oncology.
[16] E. Nemecek,et al. Antibody-based therapy of human leukemia , 2002, Current opinion in hematology.
[17] J. Nomdedéu,et al. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia , 2001, Bone Marrow Transplantation.
[18] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[19] D. Arthur,et al. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) – a report of the Children’s Cancer Group , 1999, Leukemia.
[20] A. Look,et al. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. , 1997, Blood.
[21] E. Paietta. Proposals for the immunological classification of acute leukemias. , 1995, Leukemia.
[22] A Orfao,et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.
[23] C. Cox. Multinomial regression models based on continuation ratios. , 1988, Statistics in medicine.
[24] J. Burchenal,et al. Treatment of acute lymphoblastic leukemia. , 1972, Annual review of medicine.
[25] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .